Clinically, the PIN1 promoter polymorphism may be a significant genetic determinant in the etiopathogenesis of CKD-SHPT and may serve as a biomarker of susceptibility in the Chinese Han population and Indian patients with CKD (Zhao et al., 2017; Patel et al., 2022). The gene discussed is PIN1; the disease is chronic kidney disease.